{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.dateOfAnswer=2018-11-14&ddpModified.=2018-11-14T11%3A53%3A01.575Z", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?min-answer.dateOfAnswer=2018-11-14&ddpModified.=2018-11-14T11%3A53%3A01.575Z", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.dateOfAnswer=2018-11-14&ddpModified.=2018-11-14T11%3A53%3A01.575Z&_metadata=all", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.dateOfAnswer=2018-11-14&_page=0&ddpModified.=2018-11-14T11%3A53%3A01.575Z", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.dateOfAnswer=2018-11-14&ddpModified.=2018-11-14T11%3A53%3A01.575Z", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.dateOfAnswer=2018-11-14&ddpModified.=2018-11-14T11%3A53%3A01.575Z", "items" : [{"_about" : "http://data.parliament.uk/resources/1001918", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1001918/answer", "answerText" : {"_value" : "<p>Officials have had no such discussions. Health is a devolved matter and the availability of medicines for the treatment of rare diseases in Scotland is an issue for the Scottish Government.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2018-11-14", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2018-11-14T11:21:33.263Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2018-11-05", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Rare Diseases: Drugs"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether officials in his Department have had discussions with the Scottish Government on the (a) Patient and Clinician Engagement system, (b) its effect on approval rates for new rare disease medicines in Scotland and (c) potential lessons from that system for NHS England.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4637", "label" : {"_value" : "Biography information for James Frith"}
      }
      , "tablingMemberConstituency" : {"_value" : "Bury North"}
      , "tablingMemberPrinted" : [{"_value" : "James Frith"}
      ], "uin" : "188233"}
    ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 1, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}